Press "esc" to clear
Go to Advanced Search

Showing results

110 of 466

Article ID: 702019

PhRMA Foundation and Personalized Medicine Coalition Announce 2018 Value Assessment Challenge Award Recipients

PhRMA Foundation

The PhRMA Foundation and the Personalized Medicine Coalition (PMC) have announced the recipients of the 2018 Value Assessment Challenge Awards – designed to encourage innovative approaches in defining and measuring value in health care.

Released:
10-Oct-2018 4:35 PM EDT

Article ID: 701914

由Mayo Clinic的专业知识所支持,新Mayo Clinic GeneGuide DNA检测应用程序能提供基因检测

Mayo Clinic

Mayo Clinic与个人基因组学公司Helix发布了一种名为“Mayo Clinic GeneGuide”的新DNA产品。 该基于DNA的产品能为健康个人提供基因测试以及相关的个人健康教育。该产品由Mayo医学知识和专业经验所支持。

Released:
9-Oct-2018 2:05 PM EDT
  • Embargo expired:
    1-Oct-2018 9:00 AM EDT

Article ID: 701295

New Mayo Clinic GeneGuide DNA testing application provides genetic testing, insights backed by Mayo Clinic expertise

Mayo Clinic

Mayo Clinic released a new DNA product with Helix, a personal genomics company, called "Mayo Clinic GeneGuide." The DNA-powered product provides healthy individuals with genetic testing and insights with a focus on education. This product is backed by Mayo medical science and expertise.

Released:
28-Sep-2018 10:30 AM EDT
ChowAuto-CommIllustrationCreditZacGoh.jpg
  • Embargo expired:
    25-Sep-2018 1:00 AM EDT

Article ID: 700731

Harnessing Artificial Intelligence to Improve Drug Combination Design and Personalized Medicine

SLAS (Society for Laboratory Automation and Screening)

A new auto-commentary looks at how an emerging area of artificial intelligence, specifically the analysis of small systems-of-interest specific datasets, can be used to improve drug development and personalized medicine.

Released:
21-Sep-2018 5:05 AM EDT
MWRI.jpg

Article ID: 700995

Magee-Womens Research Institute Hosts Summit Convening Global Leaders to Chart Path for Accelerated Medical Discoveries

Health Sciences at the University of Pittsburgh

The international summit will convene leaders in reproductive biology, precision medicine, public health and global health advocacy. The experts will share groundbreaking research and will culminate with crowdsourcing ideas on how to move women’s health to the forefront of medical research.

Released:
24-Sep-2018 11:05 AM EDT
Chen_moon150.jpg

Article ID: 700961

Study seeks to improve cancer survival for Latinos, Asians and Blacks

UC Davis Comprehensive Cancer Center

UC Davis Comprehensive Cancer Center has received a $6.3 million grant from the National Cancer Institute’s (NCI) Center to Reduce Cancer Health Disparities for a 5-year study to tease out why some ethnic and racial minority groups fare worse than whites when they get cancer and to find more precise treatments to improve their chances of survival.

Released:
21-Sep-2018 5:05 PM EDT
Wells_CellStemCell_HEO.jpg
  • Embargo expired:
    20-Sep-2018 11:00 AM EDT

Article ID: 700558

Scientists Grow Human Esophagus in Lab

Cincinnati Children's Hospital Medical Center

Scientists working to bioengineer the entire human gastrointestinal system in a laboratory now report using pluripotent stem cells to grow human esophageal organoids. The newly published research in the journal Cell Stem Cell is the first time scientists have been able to grow human esophageal tissue entirely from pluripotent stem cells (PSCs), which can form any tissue type in the body.

Released:
17-Sep-2018 6:00 AM EDT
VIH_cover.jpg

Article ID: 700690

Using Next-Generation Sequencing to Target Healthcare Interventions

ISPOR—The Professional Society for Health Economics and Outcomes Research

Value in Health, the official journal of ISPOR (the professional society for health economics and outcomes research), announced the publication of a series of articles that tackle the challenges associated with assessing the value of next-generation sequencing technologies in clinical care.

Released:
18-Sep-2018 8:20 AM EDT
AviganandRosenblatt450x282.jpg

Article ID: 700674

The Cancer Center at BIDMC Opens a Personalized Immunotherapy Cancer Vaccine Facility

Beth Israel Deaconess Medical Center

The Cancer Center at Beth Israel Deaconess Medical Center (BIDMC) today announced the opening of the Randi and Brian Schwartz Family Cancer Immunotherapy and Cell Manipulation Facility. The state-of-the-art laboratory expands BIDMC’s research capacity with the ultimate goal of accelerating the delivery of new immunotherapies to patients with cancer.

Released:
17-Sep-2018 4:40 PM EDT

Showing results

110 of 466

Chat now!